• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

III 期左侧结肠癌患者的不同临床病理特征及良好预后

Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer.

作者信息

Huang Ching-Wen, Tsai Hsiang-Lin, Huang Ming-Yii, Huang Chun-Ming, Yeh Yung-Sung, Ma Cheng-Jen, Wang Jaw-Yuan

机构信息

Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Department of Surgery, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

出版信息

World J Surg Oncol. 2015 Aug 28;13:257. doi: 10.1186/s12957-015-0640-4.

DOI:10.1186/s12957-015-0640-4
PMID:26311139
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4551706/
Abstract

BACKGROUND

We evaluated the clinicopathologic features and outcomes of Taiwanese patients with right-sided versus left-sided colon cancer according to various cancer stages.

METHODS

A total of 1095 patients with primary colorectal cancer (CRC) undergoing surgery at a single-institution were enrolled. We analyzed patient differences in terms of clinicopathologic features, overall survival (OS) and cancer-specific survival (CSS) of right- versus left-sided colon cancer.

RESULTS

Right-sided colon cancers were noted in 249 (22.7%) patients, and left-sided colon cancers were noted in 846 (77.3%) patients. Right-sided colon cancers were found to be significantly larger (P = 0.003) and poorly differentiated (P < 0.001), while also exhibiting advanced depth of tumor invasion (P = 0.002) and advanced UICC/AJCC stage (P = 0.016). Patients with right-sided colon cancers had both poorer OS and CSS than those with left-sided colon cancers (P = 0.021 and 0.023, respectively). However, analysis by various stages revealed significant OS and CSS differences (P = 0.002 and 0.002, respectively) between right-sided and left-sided colon cancers only in stage III patients.

CONCLUSIONS

This study demonstrated poorer OS and CSS in patients with right-sided versus those with left-sided colon cancers, but significant differences were noted only in stage III patients.

摘要

背景

我们根据不同癌症分期评估了台湾右侧结肠癌患者与左侧结肠癌患者的临床病理特征及预后。

方法

共纳入了1095例在单一机构接受手术的原发性结直肠癌(CRC)患者。我们分析了右侧结肠癌与左侧结肠癌患者在临床病理特征、总生存期(OS)和癌症特异性生存期(CSS)方面的差异。

结果

249例(22.7%)患者为右侧结肠癌,846例(77.3%)患者为左侧结肠癌。发现右侧结肠癌明显更大(P = 0.003)且分化程度低(P < 0.001),同时肿瘤浸润深度更深(P = 0.002)且UICC/AJCC分期更晚(P = 0.016)。右侧结肠癌患者的OS和CSS均比左侧结肠癌患者差(分别为P = 0.021和0.023)。然而,按不同分期分析显示,仅在III期患者中,右侧结肠癌与左侧结肠癌之间的OS和CSS存在显著差异(分别为P = 0.002和0.002)。

结论

本研究表明,右侧结肠癌患者的OS和CSS比左侧结肠癌患者差,但仅在III期患者中存在显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c450/4551706/479b4d13d6f9/12957_2015_640_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c450/4551706/3678211fce30/12957_2015_640_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c450/4551706/ea20fadba04e/12957_2015_640_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c450/4551706/479b4d13d6f9/12957_2015_640_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c450/4551706/3678211fce30/12957_2015_640_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c450/4551706/ea20fadba04e/12957_2015_640_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c450/4551706/479b4d13d6f9/12957_2015_640_Fig3_HTML.jpg

相似文献

1
Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer.III 期左侧结肠癌患者的不同临床病理特征及良好预后
World J Surg Oncol. 2015 Aug 28;13:257. doi: 10.1186/s12957-015-0640-4.
2
Lower survival after right-sided versus left-sided colon cancers: Is an extended lymphadenectomy the answer?右侧结肠癌与左侧结肠癌相比生存率较低:扩大淋巴结清扫术是答案吗?
Surg Oncol. 2018 Sep;27(3):449-455. doi: 10.1016/j.suronc.2018.05.031. Epub 2018 May 29.
3
Is there a difference in survival between right- versus left-sided colon cancers?右侧结肠癌与左侧结肠癌的生存率有差异吗?
Ann Surg Oncol. 2008 Sep;15(9):2388-94. doi: 10.1245/s10434-008-0015-y. Epub 2008 Jul 12.
4
Right-Sided and Left-Sided Colon Cancers are Two Distinct Disease Entities: an Analysis of 200 Cases in Pakistan.右侧结肠癌和左侧结肠癌是两种不同的疾病实体:巴基斯坦200例病例分析。
Asian Pac J Cancer Prev. 2016;17(5):2545-8.
5
Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study.IV 期结肠癌肿瘤位置对预后的影响:多中心研究中的倾向评分分析。
Int J Surg. 2014;12(9):925-30. doi: 10.1016/j.ijsu.2014.07.270. Epub 2014 Aug 1.
6
Better survival in right-sided versus left-sided stage I - III colon cancer patients.右侧与左侧I - III期结肠癌患者的生存情况更佳。
BMC Cancer. 2016 Jul 28;16:554. doi: 10.1186/s12885-016-2412-0.
7
Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer.KRAS和TP53突变对左、右侧杜克C期结肠癌患者生存的影响。
Am J Gastroenterol. 2000 Oct;95(10):2953-7. doi: 10.1111/j.1572-0241.2000.02327.x.
8
Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology.右半结肠癌和左半结肠癌在患者特征、癌症形态及组织学方面的差异。
J Gastroenterol Hepatol. 2008 Mar;23(3):418-23. doi: 10.1111/j.1440-1746.2007.04923.x. Epub 2007 May 27.
9
[Analysis of clinicopathologic and survival characteristics in patients with right-or left-sided colon cancer].[右半结肠癌与左半结肠癌患者的临床病理及生存特征分析]
Zhonghua Yi Xue Za Zhi. 2015 Jul 28;95(28):2268-71.
10
Difference in Time to Locoregional Recurrence Between Patients With Right-Sided and Left-Sided Colon Cancers.右侧结肠癌与左侧结肠癌患者局部区域复发时间的差异。
Dis Colon Rectum. 2015 Sep;58(9):831-7. doi: 10.1097/DCR.0000000000000426.

引用本文的文献

1
Outcomes of upfront primary tumor resection in patients with synchronous wild-type metastatic colorectal cancer.同步野生型转移性结直肠癌患者 upfront 原发性肿瘤切除的结局
Am J Cancer Res. 2024 Dec 15;14(12):5863-5873. doi: 10.62347/DLWI1455. eCollection 2024.
2
Distinct microbes, metabolites, and the host genome define the multi-omics profiles in right-sided and left-sided colon cancer.不同的微生物、代谢物和宿主基因组决定了右半结肠癌和左半结肠癌的多组学特征。
Microbiome. 2024 Dec 28;12(1):274. doi: 10.1186/s40168-024-01987-7.
3
Survival trends for left and right sided colon cancer using population-based SEER database: A forty-five-year analysis from 1975 to 2019.

本文引用的文献

1
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
2
The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer.结直肠癌患者接受手术治疗后的肿瘤部位、临床病理特征与癌症特异性生存的关系。
Colorectal Dis. 2012 Dec;14(12):1493-9. doi: 10.1111/j.1463-1318.2012.03048.x.
3
Colorectal cancer: a tale of two sides or a continuum?结直肠癌:是两种不同情况还是一个连续统一体?
基于人群的 SEER 数据库的左、右半结肠癌生存趋势:1975 年至 2019 年的 45 年分析。
Cancer Med. 2024 Apr;13(8):e7145. doi: 10.1002/cam4.7145.
4
Unraveling the role of tumor sidedness in prognosis of stage II colon cancer.探究肿瘤部位对II期结肠癌预后的影响。
Gastroenterol Rep (Oxf). 2024 Apr 12;12:goae028. doi: 10.1093/gastro/goae028. eCollection 2024.
5
Safety and Efficacy Analysis of Radical Surgery for 403 Patients with Colon Cancer over 80 Years Old.403例80岁以上结肠癌患者根治性手术的安全性和疗效分析
J Cancer. 2024 Mar 25;15(9):2837-2844. doi: 10.7150/jca.94016. eCollection 2024.
6
Survival benefit of metastasectomy in first-line cetuximab therapy in patients with RAS wild-type metastatic colorectal cancer: a nationwide registry.RAS野生型转移性结直肠癌患者一线西妥昔单抗治疗中转移灶切除术的生存获益:一项全国性登记研究
Am J Cancer Res. 2023 Dec 15;13(12):6333-6345. eCollection 2023.
7
Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer.局部晚期结肠癌治疗的生物标志物的全面综述。
Cells. 2022 Nov 23;11(23):3744. doi: 10.3390/cells11233744.
8
American Indian/Alaska Native and black colon cancer patients have poorer cause-specific survival based on disease stage and anatomic site of diagnosis.美国印第安人/阿拉斯加原住民和黑人结肠癌患者的疾病特异性生存率较差,这取决于疾病分期和诊断的解剖部位。
Cancer Epidemiol. 2022 Oct;80:102229. doi: 10.1016/j.canep.2022.102229. Epub 2022 Jul 21.
9
Risk of colon cancer-related death in people who had cancer in the past.曾经患有癌症的人罹患结肠癌相关死亡的风险。
Int J Colorectal Dis. 2022 Aug;37(8):1785-1797. doi: 10.1007/s00384-022-04202-x. Epub 2022 Jul 7.
10
Genomic and Metabolomic Landscape of Right-Sided and Left-Sided Colorectal Cancer: Potential Preventive Biomarkers.右侧和左侧结直肠癌的基因组和代谢组学特征:潜在的预防生物标志物。
Cells. 2022 Feb 3;11(3):527. doi: 10.3390/cells11030527.
Gut. 2012 Jun;61(6):794-7. doi: 10.1136/gutjnl-2012-302014. Epub 2012 Apr 5.
4
Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the colon.肿瘤位置是结直肠低分化腺癌、黏液腺癌和印戒细胞癌的预后因素。
Int J Colorectal Dis. 2012 Mar;27(3):371-9. doi: 10.1007/s00384-011-1343-0. Epub 2011 Nov 4.
5
Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results--Medicare data.右侧结肠癌与左侧结肠癌的各期死亡率:监测、流行病学和最终结果——医疗保险数据的分析。
J Clin Oncol. 2011 Nov 20;29(33):4401-9. doi: 10.1200/JCO.2011.36.4414. Epub 2011 Oct 3.
6
Variations in demography and prognosis by colon cancer location.结直肠癌位置的人口统计学和预后差异。
Anticancer Res. 2011 Jun;31(6):2347-50.
7
Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes.与生存和 TNM 分期相关的结直肠腺癌的肿瘤位置和患者特征。
BMC Cancer. 2010 Dec 21;10:688. doi: 10.1186/1471-2407-10-688.
8
Colorectal cancer molecular biology moves into clinical practice.结直肠癌分子生物学进入临床实践。
Gut. 2011 Jan;60(1):116-29. doi: 10.1136/gut.2009.206250. Epub 2010 Oct 4.
9
Proximal tumors are associated with greater mortality in colon cancer.近端肿瘤与结肠癌患者死亡率升高相关。
J Gen Intern Med. 2010 Nov;25(11):1157-63. doi: 10.1007/s11606-010-1460-4.
10
Outcome of right- and left-sided colonic and rectal cancer following surgical resection.右半结肠和左半结肠直肠癌手术后的结果。
Colorectal Dis. 2011 Aug;13(8):884-9. doi: 10.1111/j.1463-1318.2010.02356.x. Epub 2010 Jun 28.